Using bioimpedance analysis to manage fluid in hemodialysis patients
Target Weight Guided by Bioimpedance Analysis in Hemodialysis Patients
NA · Cishan Hospital, Ministry of Health and Welfare · NCT06573567
This study is testing if using a special method to manage fluid levels can help people on hemodialysis avoid serious health problems and feel better overall.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Cishan Hospital, Ministry of Health and Welfare (other) |
| Locations | 1 site (Kaohsiung) |
| Trial ID | NCT06573567 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to determine if bioimpedance-guided fluid management can reduce complications associated with hemodialysis, particularly major cardiovascular events and other symptoms like hypotension and fatigue. Participants will be divided into two groups: one receiving bioimpedance analysis to adjust their dry weight and another following standard physician recommendations without bioimpedance data. The study will monitor outcomes such as cardiovascular events, vascular access issues, and overall patient symptoms during hemodialysis. The goal is to improve patient care and outcomes in those undergoing maintenance hemodialysis.
Who should consider this trial
Good fit: Ideal candidates are patients who have been on hemodialysis for at least three months and have intact upper and lower extremities for measurement.
Not a fit: Patients who are pregnant, have a cardiac pacemaker, or possess metallic implants that interfere with measurements may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce complications and improve the quality of life for patients on hemodialysis.
How similar studies have performed: While bioimpedance analysis is a novel approach in this specific context, similar studies have shown promise in managing fluid status in other patient populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Has received hemodialysis \>= 3 months * Has at least 1 pair of intact same-side upper extremity and lower extremity Exclusion Criteria: * Pregnant * With a cardiac pacemaker * With metallic implants that may interfere with measurements (cardiac stents acceptable)
Where this trial is running
Kaohsiung
- Cishan Hospital, MOHW, Taiwan — Kaohsiung, Taiwan (RECRUITING)
Study contacts
- Study coordinator: Han-Ming Kuo, Master
- Email: khm201209@gmail.com
- Phone: +886-920132779
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hemodialysis Complication